Cyclosporin A response and dependence in children with acquired aplastic anaemia: A multicentre retrospective study with long-term observation follow-up

British Journal of Haematology

Volumn 140, Issue 2, 2008, Pages 197-205

  Saracco, Paola ^a   Quarello, Paola ^a   Iori, Anna Paola ^b   Zecca, Marco ^c   Longoni, Daniela ^d   Svahn, Johanna ^e   Varotto, Stefania ^f   Del Vecchio, Gian Carlo ^g   Dufour, Carlo ^e   Ramenghi, Ugo ^a   Bacigalupo, Andrea ^h   Locasciulli, Anna ⁱ  

^a UNIVERSITY OF TURIN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Aplastic anaemia; Children; Therapy

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYELODYSPLASIA; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; RELAPSE; SURVIVAL; TREATMENT RESPONSE;

ADOLESCENT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; RECURRENCE; TREATMENT OUTCOME;

EID: 37249068118     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06903.x     Document Type: Article

References (26)

1. Ades, L., Mary, J.Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E. Socie, G. (2004) Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood, 103, 2490 2497.
2. Bacigalupo, A., Hows, J., Gluckman, E., Nissen, C., Marsh, J., Van Lint, M.T., Congiu, M., De Planque, M.M., Ernst, P., McCann, S., Ragavashar, A., Frickhoffen, N., Wursch, A., Marmont, A.M. Gordon-Smith, E.C. (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. British Journal of Haematology, 70, 177 182.
3. Bacigalupo, A., Brand, R., Oneto, R., Bruno, B., Socie, G., Passweg, J., Locasciulli, A., Van Lint, M.T., Tichelli, A., McCann, S., Marsh, J., Ljungman, P., Hows, J., Marin, P. Schrezenmeier, H. (2000a) Treatment of acquired aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy. Seminars in Hematology, 37, 69 80.
4. Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Carotenuto, M., Coser, P., Barbui, T., Leoni, P. Ferster, A. (2000b) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood, 95, 1931 1934.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. Sultan, C. (1984) Myelodysplastic syndromes: is another classification necessary? British Journal of Haematology, 56, 515 517.
6. Camitta, B.M., Rappeport, J.M., Parkman, R. Nathan, D.G. (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood, 45, 355 363.
7. Davies, J.K. Guinan, E.C. (2007) An update on the management of severe idiopatic acquired aplastic anemia in children. British Journal of Haematology, 136, 549 564.
8. Frickhofen, N., Heimpel, H., Kaltwasser, J.P. Schrezenmeier, H. (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood, 101, 1236 1242.
9. Fuhrer, M., Rampf, U., Baumann, I., Faldum, A., Niemeyer, C., Janka-Schaub, G., Friedrich, W., Ebell, W., Borkhardt, A. Bender-Goetze, C. (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood, 106, 2102 2104.
10. Fuhrer, M., Durner, J., Brunnler, G., Gotte, H., Deppner, C., Bender-Gotze, C. Albert, E. (2007) HLA association is different in children and adults with severe acquired aplastic anemia. Pediatric Blood & Cancer, 48, 186 191.
11. Gooley, T.A., Leisenring, W., Crowley, J. Storer, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695 706.
12. Klein, J.P., Rizzo, J.D., Zhang, M.J. Keiding, N. (2001) Statistical methods for analysis and presentation of the results of bone marrow transplants, part I: unadjusted analysis. Bone Marrow Transplantation, 28, 909 915.
13. Kojima, S., Ohara, A., Tsuchida, M., Kudoh, T., Hanada, R., Okimoto, Y., Kaneko, T., Takano, T., Ikuta, K. Tsukimoto, I. (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood, 100, 786 790.
14. Locasciulli, A., Bruno, B., Rambaldi, A., Saracco, P., Dufour, C., Finelli, C., Sica, S., Varotto, S., Arcese, W., Locatelli, F., Soligo, D. Bacigalupo, A. (2004) Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Haematologica, 89, 1054 1061.
15. Marsh, J., Schrezenmeier, H., Marin, P., Ilhan, O., Ljungman, P., McCann, S., Socie, G., Tichelli, A., Passweg, J., Hows, J., Raghavachar, A., Locasciulli, A. Bacigalupo, A. (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood, 93, 2191 2195.
16. Maschan, A., Bogatcheva, N., Kryjanovskii, O., Shneider, M., Litvinov, D., Mitiushkina, T., Timakov, A., Timakova, M., Samotchatova, E. Rumiantsev, A. (1999) Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia. British Journal of Haematology, 106, 967 970.
17. Nakao, S., Takamatsu, H., Chuhjo, T., Ueda, M., Shiobara, S., Matsuda, T., Kaneshige, T. Mizoguchi, H. (1994) Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood, 84, 4257 4261.
18. Ohara, A., Kojima, S., Hamajima, N., Tsuchida, M., Imashuku, S., Ohta, S., Sasaki, H., Okamura, J., Sugita, K., Kigasawa, H., Kiriyama, Y., Akatsuda, J. Tsukimoto, I. (1997) Myelodisplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood, 90, 1009 1013.
19. Rosenfeld, S., Follmann, D., Nunez, O. Young, N.S. (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA, 289, 1130 1135.
20. Sakaeda, T., Iijima, K., Nozu, K., Nakamura, T., Moriya, Y., Nishikawa, M., Wada, A., Okamura, N., Matsuo, M. Okumura, K. (2006) Prediction of systemic exposure to cyclosporine in Japanese pediatric patients. J Hum Genet, 51, 969 976.
21. Saunthararajah, Y., Nakamura, R., Nam, J.M., Robyn, J., Loberiza, F., Maciejewski, J.P., Simonis, T., Molldrem, J., Young, N.S. Barrett, A.J. (2002) HLA-DR15 (DR2) is overrepresented in myelodisplastic syndrome and aplastic anemia and predicts response to immunosuppression in myelodisplastic syndrome. Blood, 100, 1570 1574.
22. Socie, G., Mary, J.Y., Schrezenmeier, H., Marsh, J., Bacigalupo, A., Locasciulli, A., Fuhrer, M., Bekassy, A., Tichelli, A. Passweg, J. (2006) Granulocyte stimulating factor and severe aplastic anemia. A survey by the European Group for Blood and Marrow transplantation (EBMT). Blood, 109, 2794 2796.
23. Speck, B., Gluckman, E., Haak, H.L. van Rood, J.J. (1977) Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet, 2, 1145 1148.
24. Viale, M., Bacigalupo, A., Ferrini, S. Nicolin, A. (1992) Effect of cyclosporin A on T cell clones from severe aplastic anemia: differential sensitivity of TNF and GM-CSF production. Haematologica, 77, 237 242.
25. Viollier, R., Passweg, J., Gregor, M., Favre, G., Kuhne, T., Nissen, C., Gratwohl, A. Tichelli, A. (2005) Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Annals of Hematology, 84, 47 55.
26. Weber, L.T., Armstrong, V.W., Shipkova, M., Feneberg, R., Wiesel, M., Mehls, O., Zimmerhackl, L.B., Oellerich, M. Tonshoff, B. (2004) Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection. Therapeutic Drug Monitoring, 26, 415 424.